Singapore, Sept. 3 -- Amgen hasannounced plans to invest more than$600 millionin a new, state-of-the-art centre for science and innovation at its global headquarters inThousand Oaks, California, US.

The centre is designed to bring together researchers, engineers and scientists across disciplines to enhance collaboration and accelerate the discovery of next-generation therapeutics for patients with the most serious diseases. The building will feature advanced automation and digital capabilities, empowering scientists with the tools and environment needed to drive scientific excellence and advancements in biotechnology.

Amgen's long-standing commitment to US innovation and state-of-the-art operations is reflected in more than$40 billionin...